Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00950157Not ApplicableCompleted

Testing the Effect of a Caution for Drugs Approved on Surrogate Outcomes Alone

Role: collaborator

NCT00950014Not ApplicableCompleted

Testing Numeric Formats for Presenting Data About Treatment Benefits and Harms

Role: collaborator

NCT00950131Not ApplicableCompleted

Testing the Effect of a Warning About New Drugs

Role: collaborator

NCT00915291Not ApplicableCompleted

Evaluating Effectiveness of Educational Intervention to Help Physicians Address Inappropriate Patient Requests for Direct-to-Consumer Advertised Prescription Medications

Role: collaborator

All 4 trials loaded